Systemic Therapies: Reserved for Refractory Cases For patients with severe or refractory CHE, systemic therapies such as oral retinoids (e.g., alitretinoin) and immunosuppressants (e.g., cyclosporine, methotrexate) may be considered [91]
Natural approaches through whole foods are generally safe, but individuals with diabetes should consult their GP or diabetes specialist before making significant dietary changes
Furthermore, a critical look at the studies reporting the influence of some oxidative stress gene polymorphisms on vitiligo is provided
[124] In SUSTAIN-1 (NCT02054897), a 30-week trial involving 388 drug-nave patients, semaglutide 1.0 mg monotherapy reduced HbA1c by 1.45% from baseline (versus an increase of 0.02% with placebo) and led to a mean body weight loss of 3.7 kg (versus 1.0 kg gain with placebo).30013-X/fulltext) Gastrointestinal adverse events were more frequent with semaglutide but similar in nature to other GLP-1 receptor agonists.30013-X/fulltext) SUSTAIN-2 (NCT01930188), a 56-week study in 1,231 patients inadequately controlled on metformin, compared semaglutide to sitagliptin 100 mg daily
Lipotropic Injections: Do They Work for Weight Loss